Jinqiu (Edward) Tang

Chief Financial Officer

Mr. Jinqiu (Edward) Tang has served as Anpac Bio’s Corporate Controller since October 2019 before becoming Chief Financial Officer. His experience includes:

  • Served as a global internal auditor at Natuzzi S.p.A.
  • Worked at Beijing Dongshen CPA and Shanghai De’an CPA providing external audit, finance, and tax advisory services across different industries and sectors.
  • Certified Public Accountant in Australia.
  • Received bachelor’s degree in accounting from Charles Sturt University in Australia, his MBA from Charles Sturt University in Australia, and his bachelor’s degree in law from Southwest University of Science and Technology in China.

Our world class leaders started with a question, “What if we could detect cancer before tumors start?”

Our Leadership Team

Over 200 patent applications filed globally with 107 patent applications issued.*

Our patented Cancer Differentiation Analysis (CDA) technology reinvents cancer screening and early detection with a “Blood Biopsy” that has no side effects in patients.

*As of September 30, 2019

“game changing”

CDA technology is called “game-changing” in Nobel Prize Laureate Summit on Biomedical Science (NPLS) publications.

Read the full article
©2019 Anpac Bio-Medical Science Co., Ltd.